Latest Operational Restructuring News

Cardiex Limited reported a $2.06 million cash outflow for Q3 2025 but is driving cost savings and new revenue streams while planning a capital raise to reach positive cash flow.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Entertainment Rewards Ltd reports its strongest Q3 revenue in three years, driven by growth in Frequent Values and Paid Advertising, alongside a significant debt restructuring that reclassifies $22.5 million as equity.

Oliver’s Real Food reported an 18% revenue decline in the March 2025 quarter, impacted by store closures and trading calendar shifts, yet achieved a strong rebound in EBITDA margin to 11.5%.

MyEco Group is streamlining its manufacturing footprint and expanding outsourced production to cut fixed costs by up to $3 million annually, aiming to enhance margins and achieve positive EBITDA in the medium term.

Orora Limited reported a robust first half of FY25 with underlying EBIT rising 24.6%, driven by strategic portfolio simplification and organic growth investments despite challenges in the Australian wine market.

Orora Limited reported a substantial half-year profit of A$907.6 million, propelled by the sale of its North America packaging business and strategic restructuring. The company also announced an unfranked interim dividend of 5 cents per share.

Maggie Beer Holdings reports a sales increase for 1H FY25 but faces declining EBITDA, prompting a strategic overhaul focused on cost reduction and operational streamlining.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Field Solutions Holding Ltd reported a positive net cash flow from operations for the December quarter but faces significant investing outflows and is currently in voluntary suspension pending a capital raise.